Importer of Controlled Substances; Notice of Application, 10067-10068 [2011-3945]
Download as PDF
<![CDATA[
10067
Federal Register / Vol. 76, No. 36 / Wednesday, February 23, 2011 / Notices
mstockstill on DSKH9S0YB1PROD with NOTICES
comment until March 25, 2011. This
process is conducted in accordance with
5 CFR 1320.10. To ensure that
comments on the information collection
are received, OMB recommends that
written comments be faxed to the Office
of Information and Regulatory Affairs,
OMB, Attn: DOJ Desk Officer, Fax: 202–
395–7285, or be e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number [1140–0078]. Also,
include the DOJ docket number found
in brackets in the heading of this
document. If you have questions
concerning the collection, please
contact William Miller,
William.Miller@atf.gov or the DOJ Desk
Officer at 202–395–3176.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Limited Permittee Transaction Record.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: None. Bureau
of Alcohol, Tobacco, Firearms and
Explosives.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Business or other forprofit. Other: Individuals or households.
Abstract: The purpose of this collection
is to ensure that records are available for
tracing explosive materials when
VerDate Mar<15>2010
18:50 Feb 22, 2011
Jkt 223001
necessary and to ensure that limited
permittees do not exceed their
maximum allotment of receipts of
explosive materials.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: There will be an estimated
5,000 respondents, who will spend
approximately 5 minutes to receive, file,
and forward the appropriate
documentation.
(6) An estimate of the total burden (in
hours) associated with the collection:
There are an estimated 12,000 total
burden hours associated with this
collection.
If additional information is required
contact: Lynn Murray, Department
Clearance Officer, United States
Department of Justice, Policy and
Planning Staff, Justice Management
Division, Two Constitution Square,
Room 2E–502, 145 N Street, NE.,
Washington, DC 20530.
Dated: February 16, 2011.
Lynn Murray,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. 2011–3952 Filed 2–22–11; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Industrial
Macromolecular Crystallography
Association
Correction
In notice document 2011—2412
appearing on page 6497 in the issue of
Friday, February 4, 2011, make the
following corrections:
1. On page 6497, in the second
column, in the document’s subject,
‘‘Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Industrial Nacromolecular
Crystallography Association’’ should
read ‘‘Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Industrial Macromolecular
Crystallography Association’’.
2. On the same page, in the second
column, in the fourth line from the
bottom, ‘‘Industrial Nacromolecular’’
should read ‘‘Industrial
Macromolecular.’’
3. On the same page, in the second
column, in the third line from the
bottom, ‘‘(‘‘INCA’’)’’ should read
‘‘(‘‘IMCA’’)’’.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
4. On the same page, in the third
column, in the fifth line of the second
paragraph, ‘‘INCA’’ should read ‘‘IMCA’’.
5. On the same page, in the third
column, in the first line of the third
paragraph, ‘‘INCA’’ should read ‘‘IMCA’’.
[FR Doc. C1–2011–2412 Filed 2–22–11; 8:45 am]
BILLING CODE 1505–01–D
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on January
4, 2011, Sigma Aldrich Manufacturing
LLC., 3500 Dekalb Street, St. Louis,
Missouri 63118, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Alpha-ethyltryptamine (7249) .......
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (MDMA) (7405).
4-Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
E:\FR\FM\23FEN1.SGM
23FEN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
10068
Federal Register / Vol. 76, No. 36 / Wednesday, February 23, 2011 / Notices
Drug
Schedule
mstockstill on DSKH9S0YB1PROD with NOTICES
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
N-Benzylpiperazine (BZP) (7493)
Heroin (9200) ...............................
Normorphine (9313) .....................
Etonitazene (9624) .......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone (7379) ............................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Diprenorphine (9058) ...................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium, powdered (9639) .............
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Dated: February 15, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–3945 Filed 2–22–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances may file comments or
objections to the issuance of the
proposed registration and may, at the
same time, file a written request for a
hearing on such application pursuant to
21 CFR 1301.43, and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than [insert date 30 days
from date of publication].
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
VerDate Mar<15>2010
18:50 Feb 22, 2011
Jkt 223001
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
By Notice dated November 1, 2010,
and published in the Federal Register
on November 12, 2010, 75 FR 69461,
Wildlife Laboratories, 1401 Duff Drive,
Suite 400, Fort Collins, Colorado 80524,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Etorphine Hydrochloride (9059), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance for sale to its
customer.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and § 952(a)
and determined that the registration of
Wildlife Laboratories to import the basic
class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Wildlife Laboratories to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
PO 00000
Frm 00065
Fmt 4703
Sfmt 9990
Dated: February 15, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–3948 Filed 2–22–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 6, 2011,
Johnson Matthey Pharmaceutical
Materials Inc., Pharmaceutical Service,
25 Patton Road, Devens, Massachusetts
01434, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Nabilone (7379) ............................
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Hydrocodone (9193) .....................
Schedule
II
II
II
II
II
II
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to the company’s
customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than April 25, 2011.
Dated: February 15, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–3928 Filed 2–22–11; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 76, Number 36 (Wednesday, February 23, 2011)]
[Notices]
[Pages 10067-10068]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-3945]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
regulation under 21 U.S.C. 952(a)(2) authorizing the importation of
such a substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice
that on January 4, 2011, Sigma Aldrich Manufacturing LLC., 3500 Dekalb
Street, St. Louis, Missouri 63118, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as an importer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
Aminorex (1585)............................ I
Gamma Hydroxybutyric Acid (2010)........... I
Methaqualone (2565)........................ I
Alpha-ethyltryptamine (7249)............... I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
3,4-Methylenedioxyamphetamine (7400)....... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (MDMA) I
(7405).
4-Methoxyamphetamine (7411)................ I
Bufotenine (7433).......................... I
[[Page 10068]]
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(7470).
N-Benzylpiperazine (BZP) (7493)............ I
Heroin (9200).............................. I
Normorphine (9313)......................... I
Etonitazene (9624)......................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Glutethimide (2550)........................ II
Nabilone (7379)............................ II
Phencyclidine (7471)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Diprenorphine (9058)....................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Diphenoxylate (9170)....................... II
Ecgonine (9180)............................ II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Levorphanol (9220)......................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Morphine (9300)............................ II
Thebaine (9333)............................ II
Opium, powdered (9639)..................... II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances may file comments or objections to the issuance of the
proposed registration and may, at the same time, file a written request
for a hearing on such application pursuant to 21 CFR 1301.43, and in
such form as prescribed by 21 CFR 1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than [insert date 30 days from date of publication].
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, (40 FR 43745-46), all
applicants for registration to import a basic class of any controlled
substance in schedule I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: February 15, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-3945 Filed 2-22-11; 8:45 am]
BILLING CODE 4410-09-P
